1887

OECD Science, Technology and Innovation Outlook 2016

image of OECD Science, Technology and Innovation Outlook 2016

The fully revamped and re-titled OECD Science, Technology and Innovation Outlook is a biennial publication that aims to inform policy makers and analysts on recent and future changes in global science, technology and innovation (STI) patterns and their potential implications on and for national and international STI policies. Based on the most recent data available, the report provides comparative analysis of new policies and instruments being used in OECD countries and a number of major emerging economies (including Brazil, China, India, Indonesia, the Russian Federation and South Africa) to boost the contribution of science and innovation to growth and to global and social challenges. In this edition, detailed country and policy profiles are available on line.

English French

.

Health innovation for rare diseases

Is our therapeutic innovation system in sync with public health needs? Many factors affect the health of individuals and communities. Global, socioeconomic determinants such as income and social status, education, families and communities, food and nutrition, environment, life style, and health care services have led to an epidemiological transition, leading to reduced fertility, lower mortality and ageing of populations OECD, 2016a). Despite significant advances in basic science and technology the vast majority of diseases can neither be prevented nor treated; rare diseases constitute a large part of these (Institute of Medicine, 2010). It has been argued that the current system of therapeutic innovation is not adequate to follow global health, societal and economic trends (Barker, 2016; OECD, 2015b). With a focus on rare diseases, this policy profile discusses policy measures in order to stimulate therapeutic innovation in areas of unmet medical needs.

English

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error